Vertex(US:VRTX) Xin Lang Cai Jing·2025-10-01 23:01Group 1 - Vertex Pharmaceuticals (VRTX) experienced a 3.21% increase in stock price, reaching a new high since August 2025 [1] - The rise in Vertex's stock price is attributed to positive global economic data and strong financial performance [1] - The pharmaceutical industry as a whole has shown strong performance, supporting Vertex's stock price increase [1] Group 2 - The avoidance of a government shutdown in the U.S. has alleviated regulatory risk concerns in the pharmaceutical sector, fostering optimism for future growth [1] - European market gains and strong performances from leading pharmaceutical companies like Roche, Novartis, Novo Nordisk, and Sanofi have contributed to Vertex's stock price rise [1] - The overall optimistic sentiment in global markets, driven by resilient U.S. economic growth and expectations for interest rate cuts, has bolstered confidence in the pharmaceutical sector [1]